Table 1 Comparison of clinicopathological parameters between CD133− and CD133+ ICC patients
CD133− (n = 27) | CD133+ (n = 30) | P | |
|---|---|---|---|
Age | 57.4 ± 8.4 | 60.5 ± 11.5 | 0.47 |
Gender | 0.76 | ||
Male | 19 (70.3%) | 20 (66.7%) | |
Female | 8 (29.7%) | 10 (33.3%) | |
TNM stages | |||
T | 0.37 | ||
1–2 | 14 (51.9%) | 12 (40.0%) | |
3–4 | 13 (48.1%) | 18 (60.0%) | |
N | 0.41 | ||
0 | 19 (70.4%) | 18 (60.0%) | |
1 | 8 (29.6%) | 12 (40.0%) | |
M | 0.03 | ||
0 | 24 (88.9%) | 19 (63.3%) | |
1 | 3 (10.1%) | 11 (36.7%) | |
Differentiation | 0.89 | ||
1–2 | 14 (51.9%) | 15 (50.0%) | |
3–4 | 13 (48.1%) | 15 (50.0%) | |
Recurrence | 0.02 | ||
0 | 10 (35.7%) | 3 (10.0%) | |
1 | 18 (64.3%) | 27 (90.9%) |